RiverVest promotes one and hires another

RiverVest Venture Partners said Wednesday that it has promoted Dr. Niall O’Donnell from principal to managing director. The firm has also hired Mike Berman as venture partner. Prior to joining RiverVest, O’Donnell worked at Johnson & Johnson pharmaceutical research and development in San Diego while Berman is a co-founder of eight medical technology companies including Velocimed, a RiverVest portfolio company that was bought by St. Jude Medical.

St Jude to buy AGA Medical Holdings

St Jude Medical is set to buy AGA Medical Holdings Inc, which is backed by private equity firm Welsh, Carson, Anderson and Stowe, in a deal worth more than $1 billion in stock and cash. At $20.80 a share, the deal values AGA Medical at a 41 percent premium on Friday’s closing price. AGA went public in October at $14.50 a share. St Jude said it expected to close the deal by the end of the year.

St. Jude Medical Invests $60M in CardioMEMS, With Exclusive Option to Buy

For $60 million, St. Paul, Minn.-based medical device company St. Jude Medical Signs has acquired a 19% ownership stake in CardioMEMS with an exclusive option to buy the Atlanta-based privately held company for an additional $375 million if certain commercial milestones are met. PRESS RELEASE St. Jude Medical, Inc. (NYSE: STJ), a global medical device […]

Micell Technologies Raises $15 Million

Micell Technologies, a Raleigh, N.C.-based developer of interventional cardiology systems, has raised $15 million in private equity funding from St. Jude Medical Inc. It had previously raised VC funding from Invemed Catalyst Fund and the GE Pension Plan.

PE HUB Community

Join the 12525 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget